Robinson Chandler
Monopar Therapeutics Inc. · Chief Executive Officer
Robinson Chandler is listed in filings as Chief Executive Officer at Monopar Therapeutics Inc.. This profile follows SEC Form 4 activity through Apr 2, 2026, including sale activity. Recent filings connect the profile to Monopar Therapeutics Inc. (MNPR). The current snapshot covers public activity from Jul 2, 2024 to Apr 2, 2026. Reported amounts are shown as $108.0K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||